06 Nov An Ehrlich-based perspective on the potential of tumor proteoglycan antigens as vaccines
Posted at 17:39h
in INMUNOTHERAPY
ID: 03385
Authors: Mata-Martínez, Pablo (1,2,3); Sánchez-Ruiz, Jesús (4); Bravo-Robles, Laura (1,2); Arvelo-Rosario, Daniel (2,5); Cueto, Francisco J. (2,5); Bıçakcıoğlu, Gülce (1,2); Fernández-Pascual, Jaime (1,2); Valentin, Jaime (2); López-Collazo, Eduardo (2,5); Subiza, Jose Luis (3); Viñuela, Marcos (3); del Fresno, Carlos (1,2)
Topic: INMUNOTHERAPY
Read